Procurement of Essential Pharmaceuticals for Military Personnel

The Department of Military Affairs, under the Ministry of Defence, is issuing a tender (Bid Number: GEM/2026/B/8163322) for the procurement of a comprehensive range of essential pharmaceuticals. This vital tender, originating from the Indian Army and managed by the Office Name, will commence on October 16, 2026, at 1:26 PM and conclude on October 26, 2026, at 2:00 PM. The scope of this procurement encompasses a substantial total quantity of 1,334,573 units, specifically covering a diverse list of medications. This includes, but is not limited to, Silver Sulphadiazine Cream 1%, Ofloxacin Tablets 200 mg, Aceclofenac Tablets 100 mg, Albendazole Suspension 200mg/5ml, Atropine Sulphate IP Liquid Ampoules 0.6mg/ml, Cephalexin Capsules 250 mg, Diclofenac Sodium Liquid Ampoules 25mg/ml, EtoTheophylline Liquid Ampoules, Gentamycin IP 2ml (40mg/ml) Injection, Losartan Tablets 25 mg, Metronidazole Injection 100 ml, Povidone Iodine 10% Solution 100 ml, Ranitidine HCl Tablets 150 mg, Ringer Lactate 500 ml, Trimethoprim and Sulphamethoxazole Tablets (400 mg + 80 mg), and Vitamin B Complex (sugar-coated, containing B1 5mg, B6 3mg, B12 5mcg). This procurement is critical for ensuring the health and operational readiness of military personnel, and interested parties are invited to submit their bids by the specified deadline.